Arrowhead Pharmaceuticals Statistics
Total Valuation
ARWR has a market cap or net worth of $2.77 billion. The enterprise value is $2.66 billion.
| Market Cap | 2.77B |
| Enterprise Value | 2.66B |
Important Dates
The next estimated earnings date is Tuesday, April 30, 2024, after market close.
| Earnings Date | Apr 30, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
ARWR has 123.90 million shares outstanding. The number of shares has increased by 1.30% in one year.
| Shares Outstanding | 123.90M |
| Shares Change (YoY) | +1.30% |
| Shares Change (QoQ) | +0.19% |
| Owned by Insiders (%) | 4.49% |
| Owned by Institutions (%) | 66.70% |
| Float | 118.95M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 111.11 |
| PS Ratio | 15.22 |
| Forward PS | 16.90 |
| PB Ratio | 17.25 |
| P/FCF Ratio | n/a |
| PEG Ratio | -1.32 |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 14.66 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.73, with a Debt / Equity ratio of 0.74.
| Current Ratio | 3.73 |
| Quick Ratio | n/a |
| Debt / Equity | 0.74 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -13.27 |
Financial Efficiency
Return on equity (ROE) is -95.50% and return on invested capital (ROIC) is -107.32%.
| Return on Equity (ROE) | -95.50% |
| Return on Assets (ROA) | -38.60% |
| Return on Capital (ROIC) | -107.32% |
| Revenue Per Employee | $346,171 |
| Profits Per Employee | -$565,360 |
| Employee Count | 525 |
| Asset Turnover | 0.24 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -546,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -26.69% in the last 52 weeks. The beta is 0.72, so ARWR's price volatility has been lower than the market average.
| Beta (1Y) | 0.72 |
| 52-Week Price Change | -26.69% |
| 50-Day Moving Average | 28.80 |
| 200-Day Moving Average | 29.30 |
| Relative Strength Index (RSI) | 26.77 |
| Average Volume (30 Days) | 1,271,035 |
Short Selling Information
The latest short interest is 8.87 million, so 7.16% of the outstanding shares have been sold short.
| Short Interest | 8.87M |
| Short Previous Month | 9.20M |
| Short % of Shares Out | 7.16% |
| Short % of Float | 7.46% |
| Short Ratio (days to cover) | 5.77 |
Income Statement
In the last 12 months, ARWR had revenue of $181.74 million and -$296.81 million in losses. Loss per share was -$2.77.
| Revenue | 181.74M |
| Gross Profit | 181.74M |
| Operating Income | -299.41M |
| Pretax Income | -297.36M |
| Net Income | -296.81M |
| EBITDA | -262.45M |
| EBIT | -276.52M |
| Loss Per Share | -$2.77 |
Balance Sheet
The company has $220.28 million in cash and $118.58 million in debt, giving a net cash position of $101.70 million or $0.82 per share.
| Cash & Cash Equivalents | 220.28M |
| Total Debt | 118.58M |
| Net Cash | 101.70M |
| Net Cash Per Share | $0.82 |
| Equity / Book Value | 160.41M |
| Book Value Per Share | 1.29 |
| Working Capital | 174.18M |
Cash Flow
In the last 12 months, operating cash flow was -$196.21 million and capital expenditures -$206.48 million, giving a free cash flow of -$402.70 million.
| Operating Cash Flow | -196.21M |
| Capital Expenditures | -206.48M |
| Free Cash Flow | -402.70M |
| FCF Per Share | -$3.75 |
Margins
Gross margin is 100.00%, with operating and profit margins of -164.75% and -163.32%.
| Gross Margin | 100.00% |
| Operating Margin | -164.75% |
| Pretax Margin | -163.62% |
| Profit Margin | -163.32% |
| EBITDA Margin | -144.41% |
| EBIT Margin | -152.15% |
| FCF Margin | -221.58% |
Dividends & Yields
ARWR does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.30% |
| Shareholder Yield | -1.30% |
| Earnings Yield | -10.73% |
| FCF Yield | -14.56% |
Analyst Forecast
The average price target for ARWR is $55.08, which is 146.66% higher than the current price. The consensus rating is "Buy".
| Price Target | $55.08 |
| Price Target Difference | 146.66% |
| Analyst Consensus | Buy |
| Analyst Count | 13 |
| Revenue Growth Forecast (5Y) | 32.15% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on November 17, 2011. It was a reverse split with a ratio of 1:10.
| Last Split Date | Nov 17, 2011 |
| Split Type | Reverse |
| Split Ratio | 1:10 |
Scores
ARWR has an Altman Z-Score of 0.24 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.24 |
| Piotroski F-Score | 1 |